Metabolic Syndrome: The New Silent Killer

Moderator:

Discussants:

  • Summary:

    Dr. Charles Hennekens from the Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL moderated the topic "Metabolic Syndrome: The New Silent Killer" with Drs. Felicita Andreotti from the Institute of Cardiology Catholic University Medical School, Rome, Italy, and Joan Barice from Nova Southeastern University, Davie, FL.

     

    The discussion focused primarily on:

    1) A working definition of metabolic syndrome (MetS);
    2) the definition of body mass index (BMI) and its implications for primary healthcare providers;
    3) the clinical implications of MetS in the US and worldwide;
    4) the public health implications of MetS in the US and worldwide;
    5) the adoption of therapeutic lifestyle changes (TLCs) of proven benefit to prevent and treat MetS;
    6) adjunctive drug therapies of proven benefit for the treatment of MetS;
    7) the obesity paradox;
    8) methodological biases about obesity in prospective studies;
    9) the implications of obesity and MetS in US children as well as in developing countries.
    (Med Roundtable Gen Med Ed. 2012;1(1):28–33.) ©2012 FoxP2 Media, LLC
  • Trials:

    Bogalusa Heart Study, INTERHEART, ILLUMINATE, Nurses’ Health Study, Physicians’ Health Study, Prospective Studies Collaboration

You are not authorized to access this content.

You are not authorized to access this content.
You are not authorized to access this content.
Please subscribe to use our print features or to download PDF files.